
Sign up to save your podcasts
Or


On this episode of InsideOut, we chat with Rob Barrow, CEO of the pharma development company, MindMed. MindMed has been on a quest to bring psychedelic-inspired pharmaceuticals to mainstream healthcare, and Rob believes the time is right for a radical new approach to solving some of the most challenging mental health issues the world has ever faced.
By Mike Alkire, President of Premier, Inc.5
1111 ratings
On this episode of InsideOut, we chat with Rob Barrow, CEO of the pharma development company, MindMed. MindMed has been on a quest to bring psychedelic-inspired pharmaceuticals to mainstream healthcare, and Rob believes the time is right for a radical new approach to solving some of the most challenging mental health issues the world has ever faced.